Access our full collection of sustainable healthcare resources, such as toolkits, case studies, publications and more. You can also add new resources to the library.
A really interesting paper from the Centre of Evidence Based Dermatology in Nottingham. In this project they calculated the carbon footprint of the Eczema Bathing Study, a fully remote eczema trial,…
Published date
February 2026
•
by
Vaibhav Chaganti, Emma L Campbell, Jessica Griffiths, Amanda Roberts, Lisa Fox and Kim S Thomas on behalf of the Rapid Eczema Trials team
ABSTRACTBackgroundThe burden of chronic kidney disease is increasing, driven by population aging and the increase in risk factors. In-centre haemodialysis (HD), which accounts for most of the…
Published date
December 2024
•
by
Jiménez, MDA., Audije-Gil, J., Martínez, R., Martín Vaquero, N., Gómez, M., Portillo, J., Pereda, G., Gascueña, DH., Duane, B., Sanjuan, M., Fernández Martín, JL., Dapena, F., Ortiz, A.
Frances Mortimer, CSH's Medical Director, responds to BMJ article, "Environmental Lessons Learned and Applied (ELLA): a new framework for identifying, prioritising and implementing decarbonisation…
BackgroundHaemodialysis (HD) contributes vastly to greenhouse gas (GHG) emissions. Recognizing this, the German Society for Nephrology initiated a web-based carbon footprint assessment tool to…
Published date
January 2026
•
by
Beige, J., Knöller, S., Pachmann, M., Sommer, F., Barth, HP., Masanneck, M., Kleophas, W., Schaffron, R., Stracke, S., DeGroot, K., Weinmann-Menke, J., Boedecker-Lips, SC., and Vanholder, R.
Background: Incremental hemodialysis (HD) is the process whereby the frequency of HD is adapted to the patient’s residual kidney function, initially starting at twice a week with an increase based on…
Published date
•
by
Taha, A., Messina, A., Tom, A., Altar, RI., Filteau, N., Blum, D., Trinh, E., Weber, CL.
ABSTRACTGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as game-changers across the cardiovascular–kidney–metabolic (CKM) spectrum: overweight/obesity, type 2 diabetes mellitus…
Template for submitting evidence towards the Greener Palliative Care Award.Evidence can be given toward the standards in any appropriate way. For example, minutes of meetings, sharing organisational…
Hemodialysis is a life-sustaining treatment for patients with end-stage renal disease, but it is notoriously resource-intensive, requiring vast quantities of high-purity water. This significant water…
AbstractThe burden of chronic kidney disease (CKD) and its risk factors are projected to rise in parallel with the rapidly ageing global population. By 2050, the prevalence of CKD category G3–G5 may…
Published date
July 2024
•
by
Chesnaye, NC., Ortiz, A., Zoccali, C., Stel, VS., Jager, KJ.
Purpose of reviewThe 2023 CONVINCE trial demonstrated improved survival with high-dose hemodiafiltration (HDF), prompting discussions about widespread adoption. However, this clinical advancement…
